Why Is the Aortic Valve Replacement Devices Market Growing Rapidly Worldwide?

The aortic valve replacement devices market has been witnessing significant momentum due to the rising global burden of aortic stenosis, the growing adoption of minimally invasive cardiac procedures, and consistent improvements in transcatheter technologies. As cardiovascular diseases continue to remain the leading cause of mortality worldwide, hospitals and cardiac centers are increasingly adopting advanced valve systems to improve surgical outcomes, enhance safety, and reduce recovery time for patients.

In 2024, the global aortic valve replacement devices market reached USD 8.99 Billion, and with an expected CAGR of 6.50% from 2025 to 2034, the market is forecasted to reach USD 16.88 Billion by 2034. Much of this growth is attributed to rapid advancements in transcatheter aortic valve replacement (TAVR), the rising geriatric population, and the expanding availability of specialized cardiac care in emerging economies.

This detailed report answers the key questions users commonly search for, such as market size, growth drivers, segmentation, leading companies, regional performance, and technological advancements shaping the market through 2034.

Market Overview: What Is Driving the Growth of the Aortic Valve Replacement Devices Market?

The global rise in valvular heart disease, especially aortic stenosis, is a major factor behind the increasing demand for valve replacement devices. The market is driven by:

  • Increasing prevalence of cardiovascular disorders

  • Technological advancements in transcatheter aortic valve systems

  • Strong shift toward minimally invasive cardiac surgeries

  • Rapid aging population prone to valvular calcification

  • Expanding healthcare infrastructure in Asia Pacific and Latin America

  • Higher patient preference for procedures with shorter hospital stays

Improved diagnostics, better screening programs, and investments in next-generation cardiac implants are further accelerating market adoption worldwide.

Market Size and Growth Trends (2024–2034)

  • 2024 Market Size: USD 8.99 Billion

  • 2034 Projection: USD 16.88 Billion

  • CAGR (2025–2034): 6.50%

Key Growth Trends

  • Rising adoption of TAVR: Favored due to reduced complications and faster patient recovery.

  • Growing preference for sutureless valves: Increasingly popular in patients at intermediate surgical risk.

  • Technological innovation: Companies are developing smaller, repositionable, and long-lasting valves.

  • Improved reimbursement landscape: Boosting adoption across North America and Europe.

  • Rise in outpatient cardiovascular procedures: Driving demand in ambulatory surgical centers.

Market Segmentation: A Detailed Breakdown

1. Market Breakup by Surgery Type

● Open Surgery

Open-heart aortic valve replacement remains a standard treatment option, particularly for younger patients and those unsuitable for TAVR. Although invasive, it offers long-term efficacy and durability.

● Minimally Invasive Surgery

Minimally invasive procedures, especially TAVR, are rapidly gaining traction due to:

  • Lower recovery time

  • Reduced infection risks

  • Favorable outcomes in elderly and high-risk patients

TAVR has transformed the market, becoming the most rapidly expanding segment.

2. Market Breakup by Product Type

● Transcatheter Aortic Valve (TAVR)

The most dominant and fastest-growing segment. Increasingly used in:

  • High-risk and intermediate-risk patients

  • Elderly population unable to undergo open surgery

  • Emerging markets adopting advanced catheter-based interventions

● Sutureless Aortic Valve Replacement (SUAVR)

Preferred for its reduced operative time and compatibility with minimally invasive surgeries. SUAVR is gaining acceptance among surgeons aiming for faster and safer procedures.

3. Market Breakup by End Use

● Hospitals

Hospitals remain the primary end users due to the availability of sophisticated cardiac infrastructure. Multidisciplinary teams and hybrid operating rooms boost procedure volume.

● Ambulatory Surgical Centres (ASCs)

Growth in ASCs is driven by:

  • Increasing acceptance of minimally invasive cardiac procedures

  • Lower surgical costs compared to hospitals

  • Preference for shorter outpatient recovery

● Others

Includes specialized heart institutes and research organizations contributing to advanced product trials and clinical evaluations.

4. Market Breakup by Region

● North America

  • Largest market share

  • Strong adoption of TAVR

  • Favorable reimbursement system

  • Presence of leading companies like Medtronic and Edwards Lifesciences

● Europe

  • Growing geriatric population

  • High acceptance of sutureless valve technologies

  • Advanced cardiac care facilities

● Asia Pacific

Fastest-growing region due to:

  • Improved cardiac diagnostic capabilities

  • Rising healthcare investments

  • Growing middle-class healthcare spending

● Latin America

  • Developing cardiac surgical programs

  • Increasing focus on minimally invasive treatments

● Middle East and Africa

  • Growth driven by modernization of healthcare systems

  • Increasing awareness about valve replacement procedures

Key Factors Driving the Aortic Valve Replacement Devices Market

  • Large elderly population at risk of aortic stenosis

  • Advancements in valve durability and biocompatibility

  • Increased government funding for cardiovascular healthcare

  • Rising preference for minimally invasive treatments

  • Expanding access to cardiac diagnostics and interventional cardiology services

  • Growing clinical evidence supporting TAVR in low-risk patients

Challenges and Restraints

Despite strong growth prospects, the market faces challenges such as:

  • High cost of valve replacement procedures

  • Long-term durability concerns for transcatheter valves

  • Limited access to advanced cardiac centers in underdeveloped regions

  • Strict regulatory pathways for device approval

However, ongoing innovation and broader reimbursement coverage are helping reduce cost barriers.

Competitive Landscape: Leading Companies in the Aortic Valve Replacement Devices Market

The market is dominated by major players focusing on R&D, clinical trials, and innovative product launches.

Key Companies Covered

  • Boston Scientific Corporation

  • Corcym S.r.l

  • Edwards Lifesciences Corporation

  • Medtronic plc

  • Artivion, Inc.

  • Abbott Laboratories

  • Others

These companies continue to invest heavily in next-generation valve technologies, including repositionable and retrievable devices, extended durability valves, and advanced imaging-compatible systems.

Future Outlook: What to Expect by 2034?

The aortic valve replacement devices market is expected to experience major transformations including:

  • Wide-scale use of TAVR for low-risk patients

  • Development of fully automated robotic-assisted valve replacement systems

  • Durable polymeric and tissue-engineered valves

  • Greater adoption of AI and predictive diagnostics in cardiology

  • Expansion of valve clinics in emerging markets

With continuous advancements, the market will move strongly toward less invasive, faster, and more durable valve replacement solutions.

Find More Reports

Dental Equipment Market

India Vitamin Gummies Market

India Medical Gases Market

Osteoarthritis Therapeutics Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com